• 1. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 2. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139

Professional Introduction to N-Me-lys-OH Hydrochloride (CAS No. 14000-28-3)

N-Me-lys-OH Hydrochloride, chemically designated as N-methyl-L-lysine hydrochloride, is a significant compound in the field of pharmaceutical chemistry and biochemistry. With a CAS number of 14000-28-3, this compound has garnered considerable attention due to its versatile applications in drug development and therapeutic research. The molecular structure of N-Me-lys-OH Hydrochloride incorporates a modified lysine residue, which contributes to its unique biochemical properties and potential biological activities.

The synthesis and characterization of N-Me-lys-OH Hydrochloride involve rigorous methodologies to ensure high purity and efficacy. This compound is particularly valued for its role as a building block in the synthesis of more complex peptides and proteins. Its hydrochloride salt form enhances solubility, making it an ideal candidate for various biochemical assays and pharmaceutical formulations.

Recent advancements in the field of proteomics and peptidomimetics have highlighted the importance of modified amino acids like N-Me-lys-OH Hydrochloride. These modifications can significantly alter the biological behavior of peptides, often leading to improved stability, bioavailability, and target specificity. For instance, studies have demonstrated that incorporating N-methylated lysine residues into peptide drugs can enhance their resistance to enzymatic degradation, thereby prolonging their therapeutic effects.

In the realm of drug discovery, N-Me-lys-OH Hydrochloride has been utilized in the development of novel therapeutic agents targeting various diseases. Its structural motif is frequently employed in the design of peptidomimetics that mimic natural peptide sequences while offering improved pharmacokinetic profiles. Such peptidomimetics are being explored for applications in oncology, immunology, and cardiovascular diseases, among others.

The pharmacological properties of N-Me-lys-OH Hydrochloride have been extensively studied in preclinical models. Research indicates that this compound can modulate protein-protein interactions by serving as a key residue in designed peptides. This capability is particularly relevant in developing targeted therapies that interfere with disease-causing pathways. For example, peptides incorporating N-Me-lys-OH Hydrochloride have shown promise in inhibiting the activity of kinases and other enzymes involved in cancer progression.

Moreover, the use of computational modeling and molecular dynamics simulations has further elucidated the role of N-Me-lys-OH Hydrochloride in peptide design. These computational tools allow researchers to predict how modifications at specific positions, such as the N-methylated lysine residue, can influence the overall structure and function of peptides. This approach has accelerated the discovery process by enabling rapid screening of potential candidates before experimental validation.

The industrial production of N-Me-lys-OH Hydrochloride adheres to stringent quality control measures to ensure consistency and reliability. Manufacturers employ advanced synthetic techniques, including enzymatic catalysis and chiral resolution methods, to achieve high yields and purity levels. These processes are critical for meeting the demands of pharmaceutical applications where even minor impurities can impact efficacy.

In conclusion, N-Me-lys-OH Hydrochloride (CAS No. 14000-28-3) represents a cornerstone compound in modern pharmaceutical research. Its unique structural features and functional properties make it indispensable for developing innovative therapeutic strategies across multiple disease areas. As research continues to uncover new applications for modified amino acids like lysine derivatives, the significance of compounds such as this one is expected to grow even further.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)